{"DataElement":{"publicId":"14755429","version":"1","preferredName":"Disposition Domain Study Participant Consent Withdrawal Type","preferredDefinition":"A description of the type of consent withdrawal.","longName":"DS_WDC_TP","context":"CCTG","contextVersion":"1","DataElementConcept":{"publicId":"14608858","version":"1","preferredName":"Disposition Domain Study Participant Consent Withdrawn","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to disposition.:Any individiual that has a role in a study, including study personnel and study subjects._When the permission to do something is rescinded or withdrawn.","longName":"2859364v1.00:14608857v1.00","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2859364","version":"1","preferredName":"Disposition Domain","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to disposition.","longName":"C49576","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disposition Domain","conceptCode":"C49576","definition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to disposition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"667C7B15-C9BA-53A6-E040-BB89AD43558C","latestVersionIndicator":"Yes","beginDate":"2009-04-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-04-01","modifiedBy":"ONEDATA","dateModified":"2009-04-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"14608857","version":"1","preferredName":"Study Participant Consent Withdrawn","preferredDefinition":"Any individiual that has a role in a study, including study personnel and study subjects._When the permission to do something is rescinded or withdrawn.","longName":"C142710:C48271","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Study Participant","conceptCode":"C142710","definition":"Any individiual that has a role in a study, including study personnel and study subjects.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Consent Withdrawn","conceptCode":"C48271","definition":"When the permission to do something is rescinded or withdrawn.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A9941F7-FA1B-28F9-E063-731AD00A589A","latestVersionIndicator":"Yes","beginDate":"2023-11-20","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-11-20","modifiedBy":"MMADDINENI","dateModified":"2023-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008530","version":"1","preferredName":"Patient Consent","preferredDefinition":"patients' acknowledgement and acceptance of participation in a clinical trial.","longName":"PT_CONSENT","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ECCB2D-44A9-3496-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"MAESKEB","dateModified":"2019-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A9941F7-FA1C-28F9-E063-731AD00A589A","latestVersionIndicator":"Yes","beginDate":"2023-11-20","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-11-20","modifiedBy":"KUMMEROA","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2023.12.5 Released per COG review. ak11/20/2023: Created DEC(CADSR0003083)-MM","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6763051","version":"1","preferredName":"Consent Withdrawal Type","preferredDefinition":"An explanation of the cause of some phenomenon or action._Something distinguishable as an identifiable class based on common qualities.","longName":"6763051v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Pillbox preference","valueDescription":"Pill Dosage Form Preference","ValueMeaning":{"publicId":"6769027","version":"1","preferredName":"Pill Dosage Form Preference","longName":"6769027","preferredDefinition":"A solid composed of a small, round object composed of active and/or inert ingredient(s).: The act, fact, or principle of giving advantages to some particular person, object, or course of action over others; designated as more desirable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pill Dosage Form","conceptCode":"C25394","definition":"A solid composed of a small, round object composed of active and/or inert ingredient(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Preference","conceptCode":"C41187","definition":"The act, fact, or principle of giving advantages to some particular person, object, or course of action over others; designated as more desirable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"89940BCD-CA04-2B27-E053-F662850AF290","latestVersionIndicator":"Yes","beginDate":"2019-05-23","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-05-23","modifiedBy":"ONEDATA","dateModified":"2019-05-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"89940BCD-CA1F-2B27-E053-F662850AF290","beginDate":"2019-05-17","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-05-23","modifiedBy":"ONEDATA","dateModified":"2019-05-23","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2757951","version":"1","preferredName":"Other","longName":"2757951","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F52A8FB-E278-3426-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Added concept to value meaning. mc 3/20/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8992AE39-64B9-528E-E053-F662850ACAD4","beginDate":"2019-05-17","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-05-23","modifiedBy":"ONEDATA","dateModified":"2019-05-23","deletedIndicator":"No"},{"value":"Liquid 6-MP","valueDescription":"Liquid Mercaptopurine","ValueMeaning":{"publicId":"6766526","version":"1","preferredName":"Liquid Mercaptopurine","longName":"6766526","preferredDefinition":"A substance in the fluid state of matter having no fixed shape but a fixed volume.: A thiopurine-derivative antimetabolite with antineoplastic and immunosuppressive activities.  Produced through the metabolism of mercaptopurine by hypoxanthine-guanine phosphoribosyltransferase (HGPRT), mercaptopurine metabolites 6-thioguanosine-5'-phosphate (6-thioGMP) and 6-thioinosine monophosphate (T-IMP) inhibit nucleotide interconversions and de novo purine synthesis, thereby blocking the formation of purine nucleotides and inhibiting DNA synthesis.  This agent is also incorporated into DNA in the form of deoxythioguanosine, which results in the disruption of DNA replication. In addition, mercaptopurine is converted to 6-methylmercaptopurine ribonucleoside (MMPR) by 6-thiopurine methyltransferase; MMPRs are also potent inhibitors of de novo purine synthesis. (NCI04)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liquid","conceptCode":"C45298","definition":"A substance in the fluid state of matter having no fixed shape but a fixed volume.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mercaptopurine","conceptCode":"C195","definition":"A thiopurine-derivative antimetabolite with antineoplastic and immunosuppressive activities.  Produced through the metabolism of mercaptopurine by hypoxanthine-guanine phosphoribosyltransferase (HGPRT), mercaptopurine metabolites 6-thioguanosine-5'-phosphate (6-thioGMP) and 6-thioinosine monophosphate (T-IMP) inhibit nucleotide interconversions and de novo purine synthesis, thereby blocking the formation of purine nucleotides and inhibiting DNA synthesis.  This agent is also incorporated into DNA in the form of deoxythioguanosine, which results in the disruption of DNA replication. In addition, mercaptopurine is converted to 6-methylmercaptopurine ribonucleoside (MMPR) by 6-thiopurine methyltransferase; MMPRs are also potent inhibitors of de novo purine synthesis. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8993C09D-679C-267F-E053-F662850A11C3","latestVersionIndicator":"Yes","beginDate":"2019-05-23","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-05-23","modifiedBy":"ONEDATA","dateModified":"2019-05-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8993C09D-67B5-267F-E053-F662850A11C3","beginDate":"2019-05-17","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-05-23","modifiedBy":"ONEDATA","dateModified":"2019-05-23","deletedIndicator":"No"},{"value":"Not interested in participating","valueDescription":"Negation Interest Participation","ValueMeaning":{"publicId":"6766527","version":"1","preferredName":"Negation Interest Participation","longName":"6766527","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: A state of curiosity or concern about or attention to something.: The act of taking part in an activity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Interest","conceptCode":"C60730","definition":"A state of curiosity or concern about or attention to something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Participation","conceptCode":"C25608","definition":"The act of taking part in an activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8993C09D-67C3-267F-E053-F662850A11C3","latestVersionIndicator":"Yes","beginDate":"2019-05-23","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-05-23","modifiedBy":"ONEDATA","dateModified":"2019-05-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8993C09D-67DC-267F-E053-F662850A11C3","beginDate":"2019-05-17","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-05-23","modifiedBy":"ONEDATA","dateModified":"2019-05-23","deletedIndicator":"No"},{"value":"Pillbox preference","valueDescription":"Preference Pill Dosage Form","ValueMeaning":{"publicId":"6766528","version":"1","preferredName":"Preference Pill Dosage Form","longName":"6766528","preferredDefinition":"The act, fact, or principle of giving advantages to some particular person, object, or course of action over others; designated as more desirable.: A solid composed of a small, round object composed of active and/or inert ingredient(s).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Preference","conceptCode":"C41187","definition":"The act, fact, or principle of giving advantages to some particular person, object, or course of action over others; designated as more desirable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pill Dosage Form","conceptCode":"C25394","definition":"A solid composed of a small, round object composed of active and/or inert ingredient(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8993C09D-67E9-267F-E053-F662850A11C3","latestVersionIndicator":"Yes","beginDate":"2019-05-23","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-05-23","modifiedBy":"ONEDATA","dateModified":"2019-05-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8993C09D-6802-267F-E053-F662850A11C3","beginDate":"2019-05-17","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-05-23","modifiedBy":"ONEDATA","dateModified":"2019-05-23","deletedIndicator":"No"},{"value":"Discontinue all clinical trial aspects","valueDescription":null,"ValueMeaning":{"publicId":"14755421","version":"1","preferredName":"All Clinical Trial Aspect Discontinue","longName":"14755421v1.00","preferredDefinition":"To a complete degree or to the full or entire extent._A research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes._A characteristic to be considered; a distinct feature or element._To stop or end, permanently or temporarily.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"All","conceptCode":"C64916","definition":"To a complete degree or to the full or entire extent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Clinical Trial","conceptCode":"C71104","definition":"A research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Aspect","conceptCode":"C61468","definition":"A characteristic to be considered; a distinct feature or element.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Discontinue","conceptCode":"C25484","definition":"To stop or end, permanently or temporarily.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"114543BD-86C7-4357-E063-731AD00AD26F","latestVersionIndicator":"Yes","beginDate":"2024-02-13","endDate":null,"createdBy":"CLOHNES","dateCreated":"2024-02-13","modifiedBy":"CLOHNES","dateModified":"2024-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"114543BD-86C9-4357-E063-731AD00AD26F","beginDate":"2024-02-13","endDate":null,"createdBy":"CLOHNES","dateCreated":"2024-02-13","modifiedBy":"CLOHNES","dateModified":"2024-02-13","deletedIndicator":"No"},{"value":"No further data submission","valueDescription":null,"ValueMeaning":{"publicId":"14755422","version":"1","preferredName":"No Further Data Submission","longName":"14755422v1.00","preferredDefinition":"The non-affirmative response to a question._To or at a greater distance in time or space._A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn._The act of referring for judgment or consideration by others; the act of handing over something.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Further","conceptCode":"C25519","definition":"To or at a greater distance in time or space.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Data","conceptCode":"C25474","definition":"A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Submission","conceptCode":"C25695","definition":"The act of referring for judgment or consideration by others; the act of handing over something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"114543BD-86C8-4357-E063-731AD00AD26F","latestVersionIndicator":"Yes","beginDate":"2024-02-13","endDate":null,"createdBy":"CLOHNES","dateCreated":"2024-02-13","modifiedBy":"CLOHNES","dateModified":"2024-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"114543BD-86CA-4357-E063-731AD00AD26F","beginDate":"2024-02-13","endDate":null,"createdBy":"CLOHNES","dateCreated":"2024-02-13","modifiedBy":"CLOHNES","dateModified":"2024-02-13","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008530","version":"1","preferredName":"Patient Consent","preferredDefinition":"patients' acknowledgement and acceptance of participation in a clinical trial.","longName":"PT_CONSENT","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ECCB2D-44A9-3496-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"MAESKEB","dateModified":"2019-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"891CA60C-1104-2777-E053-F662850A4D60","latestVersionIndicator":"Yes","beginDate":"2019-05-17","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-05-17","modifiedBy":"CLOHNES","dateModified":"2024-02-13","changeDescription":null,"administrativeNotes":"2/13/24 Added 2 PVs for ticket number CADSR0003395 for CCTG per AK cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"SUPPDS_QVAL_WC","type":"VM Alt Name","context":"CCTG"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"What is the consent withdrawal type?","url":null,"context":"CCTG"},{"name":"CCTG_01","type":"Alternate Question Text","description":"A patient is considered to have withdrawn their consent to participate in a clinical trial when the patient no longer wishes to participate in the clinical trial and does not want any future clinical data submitted.  Please confirm the following","url":null,"context":"CCTG"}],"origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"1145B026-321A-5940-E063-731AD00A0398","latestVersionIndicator":"Yes","beginDate":"2024-02-13","endDate":null,"createdBy":"CLOHNES","dateCreated":"2024-02-13","modifiedBy":"CLOHNES","dateModified":"2024-02-13","changeDescription":null,"administrativeNotes":"2/13/24 Created CDE and added AQT for ticket number CADSR0003395 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"}}